CBS 2019
CBSMD教育中心
中 文

Congestive Heart Failure

Abstract

Recommended Article

Clinical Phenogroups in Heart Failure With Preserved Ejection Fraction: Detailed Phenotypes, Prognosis, and Response to Spironolactone Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction: The DEFINE-HF Trial Effects of Liraglutide on Cardiovascular Outcomes in Patients With Diabetes With or Without Heart Failure Change in plasma volume and prognosis in acute decompensated heart failure: an observational cohort study Longitudinal Change in Galectin-3 and Incident Cardiovascular Outcomes Diuretic Therapy for Patients With Heart Failure: JACC State-of-the-Art Review Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction Age-Related Characteristics and Outcomes of Patients With Heart Failure With Preserved Ejection Fraction

Clinical Trial2014 Sep 11;371(11):993-1004.

JOURNAL:N Engl J Med. Article Link

Angiotensin–neprilysin inhibition versus enalapril in heart failure

McMurray JJ, Packer M, PARADIGM-HF Investigators and Committees. Keywords: angiotensin receptor-neprilysin inhibitor LCZ696; enalapril; HFrEF; mortality; survival; hospitalization for heart failure

FULL TEXT PDF